Budesonide ER Capsules
SAM.GOV Due: May 14, 2025 at 07:00 PM UTC
In-Active Solicitation Source Url

Summary

The opportunity for Budesonide ER Capsules is a solicitation issued by the Defense Logistics Agency (DLA) under solicitation number SPE2D2-25-R-0008. This procurement is aimed at acquiring extended-release capsules of Budesonide, a medication used primarily for the treatment of asthma and other respiratory conditions. Contractors with expertise in pharmaceutical manufacturing, particularly those who can meet the stringent regulatory requirements for drug production and distribution, are encouraged to bid on this opportunity. The solicitation outlines specific compliance and performance standards that must be adhered to, making it essential for bidders to have a solid understanding of the pharmaceutical supply chain and the ability to deliver high-quality products within the specified timelines.
Description

SPE2D225R0008 Budesonide ER Capsules Solicitation

Entities
DOD
Department of Defense
DLA
Defense Logistics Agency
NAICS
325412
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Christopher Newman [email protected] 4457377371 primary
Jason Wray [email protected] 2157370614 secondary
Attachments
  • SPE2D225R00080001+released.pdf
  • Budesonide+ER+SPE2D225R0008+Solicitation.pdf